Detail your involvement
2
Gilead Sciences completed the acquisition of Immunomedics for $21bn.
Service Providers
legal advisors
Wachtell Lipton Rosen & Katz
financial advisors
TD Cowen
financial advisors
Bank of America
financial advisors
Centerview Partners
legal advisors to financial advisors
Sullivan & Cromwell
legal advisors to financial advisors
Goodwin Procter
financial advisors
Lazard
financial advisors
Morgan Stanley
legal advisors
Davis Polk & Wardwell
legal advisors to financial advisors
Cravath Swaine & Moore
pr advisors
Joele Frank
financial advisors
Mizuho Securities
legal advisors to financial advisors
Fried Frank Harris Shriver & Jacobson
or
Principals
target
IMMUNOMEDICS
bidder
GILEAD SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
All rights reserved. Copyright © 2025 Datasite